Welcome to the Oncomine Blog

NGS Enables Precision Oncology in Community-Based Hospitals

10/15/2021

Next-generation sequencing (NGS) technology has changed cancer treatment by enabling pathologists and oncologists to match cancer patients with targeted therapies based on a tumor’s genetic profile. Yet not every cancer patient has access to this..

How Diagnostics can Revolutionize Patient Care: ...

Precision medicine is a holistic approach to healthcare that combines knowledge of an individuals’ ...

University of Munich Evaluates the Oncomine ...

Our OncomineWorld event in 2021 brought thousands of professionals together from around the world ...

Case Study: High-Quality, Cost-Effective Genomic ...

In a recent case study interview, pathologist Federico Jauk, head of the Sequencing Laboratory at ...

Q&A: An Inside Look at Immune Repertoire Assay ...

Dr. Geoffrey Lowman Senior Staff Scientist, Molecular Biology, Clinical Sequencing Division Thermo ...

UAB Study Evaluates the Oncomine Myeloid Research ...

Performance of the Oncomine Myeloid Research Assay GX Craig Mackinnon, MD, PhD, Director of Genomic ...

Let’s Do It Ourselves - A global expert consensus ...

Over the last decade, precision oncology therapies dependent on biomarker-based diagnostics have ...

A Comprehensive Answer for Cancer: Is ...

What is comprehensive genomic profiling (CGP)? CGP is the simultaneous detection of all classes of ...

Biomarker Tests for Precision Oncology: DIY or ...

Cancer patient management of is increasingly driven by biomarker assays – but how should we manage ...

Evaluating the Oncomine Myeloid Assay GX for ...

Dr. Yi Ding of Geisinger Medical Laboratories recently presented at the 2020 Association of ...